Replies to post #1759021 on BB's Stock Haven

[drugtester]

XNPT..yep loridans...yesterday's drop from $19.60 to $6.67 is beyond an over reaction. The FDA didn't tell Xenoport (and their partner on the drug GlaxoSmithKline) that Horizant will never receive an NDA, they just need some more data showing its safety in humans.

This might be one of the easiest plays (besides CCTC over the past two days...lol) of the year.